XBiotech Days Payables Outstanding vs Free Cash Flow Per Share Analysis

XBIT Stock

USD 7.61 0.26 3.54%

XBiotech financial indicator trend analysis is more than just analyzing XBiotech current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether XBiotech is a good investment. Please check the relationship between XBiotech Days Payables Outstanding and its Free Cash Flow Per Share accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XBiotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy XBiotech Stock please use our How to Invest in XBiotech guide.

Days Payables Outstanding vs Free Cash Flow Per Share

Days Payables Outstanding vs Free Cash Flow Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of XBiotech Days Payables Outstanding account and Free Cash Flow Per Share. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between XBiotech's Days Payables Outstanding and Free Cash Flow Per Share is -0.13. Overlapping area represents the amount of variation of Days Payables Outstanding that can explain the historical movement of Free Cash Flow Per Share in the same time period over historical financial statements of XBiotech, assuming nothing else is changed. The correlation between historical values of XBiotech's Days Payables Outstanding and Free Cash Flow Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Days Payables Outstanding of XBiotech are associated (or correlated) with its Free Cash Flow Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Per Share has no effect on the direction of Days Payables Outstanding i.e., XBiotech's Days Payables Outstanding and Free Cash Flow Per Share go up and down completely randomly.

Correlation Coefficient

-0.13

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Days Payables Outstanding

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.

Most indicators from XBiotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into XBiotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XBiotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy XBiotech Stock please use our How to Invest in XBiotech guide.At this time, XBiotech's Selling General Administrative is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 1.49 in 2024, whereas Tax Provision is likely to drop slightly above 875 K in 2024.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	2.6M	2.6M	1.8M	2.4M
Net Interest Income	467K	3.8M	10.3M	10.8M

Reconciled Depreciation Net Interest Income

XBiotech fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Other Stockholder Equity	Other Liab	Retained Earnings Total Equity	Non Currrent Assets Other
Total Assets		-0.09	0.87	0.88	1.0	0.47	-0.99	0.9	0.24	0.99	0.91	0.99	0.62	0.68	0.59	0.25	0.9	0.44	1.0	0.63	0.54	0.99	0.33	0.55	0.96	0.24
Short Long Term Debt Total	-0.09		-0.01	-0.02	-0.09	-0.17	0.15	0.01	-0.13	-0.09	-0.06	-0.09	-0.23	-0.12	-0.26	0.1	-0.03	-0.29	-0.09	-0.21	-0.24	-0.14	0.07	-0.54	-0.08	0.44
Other Current Liab	0.87	-0.01		1.0	0.85	0.22	-0.89	0.84	0.08	0.9	0.91	0.88	0.4	0.9	0.19	-0.07	0.99	0.14	0.85	0.41	0.24	0.85	-0.09	0.18	0.85	0.65
Total Current Liabilities	0.88	-0.02	1.0		0.86	0.26	-0.9	0.82	0.17	0.91	0.92	0.89	0.45	0.89	0.21	-0.06	1.0	0.18	0.86	0.46	0.26	0.86	-0.08	0.2	0.85	0.63
Total Stockholder Equity	1.0	-0.09	0.85	0.86		0.48	-0.99	0.89	0.24	0.99	0.9	0.99	0.63	0.65	0.61	0.27	0.88	0.46	1.0	0.64	0.56	0.99	0.35	0.57	0.96	0.21
Property Plant And Equipment Net	0.47	-0.17	0.22	0.26	0.48		-0.42	0.07	0.6	0.42	0.61	0.43	0.92	0.24	0.53	0.24	0.29	0.92	0.45	0.93	0.87	0.42	0.35	0.52	0.25	-0.27
Net Debt	-0.99	0.15	-0.89	-0.9	-0.99	-0.42		-0.9	-0.22	-1.0	-0.91	-0.99	-0.59	-0.71	-0.57	-0.16	-0.92	-0.41	-0.99	-0.6	-0.5	-0.99	-0.28	-0.55	-0.96	-0.27
Retained Earnings	0.9	0.01	0.84	0.82	0.89	0.07	-0.9		-0.07	0.91	0.72	0.9	0.22	0.59	0.46	0.25	0.84	0.08	0.91	0.22	0.21	0.92	0.3	0.41	0.98	0.34
Accounts Payable	0.24	-0.13	0.08	0.17	0.24	0.6	-0.22	-0.07		0.21	0.31	0.22	0.63	-0.01	0.17	0.13	0.18	0.52	0.23	0.64	0.24	0.18	0.15	0.2	0.08	-0.13
Cash	0.99	-0.09	0.9	0.91	0.99	0.42	-1.0	0.91	0.21		0.91	1.0	0.59	0.7	0.57	0.17	0.92	0.41	0.99	0.59	0.49	0.99	0.28	0.53	0.96	0.3
Non Current Assets Total	0.91	-0.06	0.91	0.92	0.9	0.61	-0.91	0.72	0.31	0.91		0.91	0.71	0.84	0.38	0.06	0.93	0.5	0.89	0.73	0.58	0.88	0.08	0.37	0.8	0.41
Cash And Short Term Investments	0.99	-0.09	0.88	0.89	0.99	0.43	-0.99	0.9	0.22	1.0	0.91		0.6	0.68	0.59	0.16	0.91	0.42	0.99	0.6	0.51	0.99	0.3	0.55	0.96	0.26
Common Stock Total Equity	0.62	-0.23	0.4	0.45	0.63	0.92	-0.59	0.22	0.63	0.59	0.71	0.6		0.38	0.55	0.14	0.47	0.87	0.6	0.99	0.86	0.57	0.23	0.55	0.4	-0.15
Common Stock Shares Outstanding	0.68	-0.12	0.9	0.89	0.65	0.24	-0.71	0.59	-0.01	0.7	0.84	0.68	0.38		-0.05	-0.14	0.87	0.08	0.65	0.41	0.26	0.65	-0.33	0.02	0.62	0.68
Non Current Liabilities Total	0.59	-0.26	0.19	0.21	0.61	0.53	-0.57	0.46	0.17	0.57	0.38	0.59	0.55	-0.05		0.18	0.26	0.72	0.61	0.53	0.69	0.61	0.78	0.95	0.55	-0.54
Other Current Assets	0.25	0.1	-0.07	-0.06	0.27	0.24	-0.16	0.25	0.13	0.17	0.06	0.16	0.14	-0.14	0.18		-0.05	0.14	0.27	0.15	0.26	0.25	0.45	0.13	0.28	-0.3
Total Liab	0.9	-0.03	0.99	1.0	0.88	0.29	-0.92	0.84	0.18	0.92	0.93	0.91	0.47	0.87	0.26	-0.05		0.21	0.88	0.48	0.29	0.88	-0.04	0.24	0.87	0.6
Property Plant And Equipment Gross	0.44	-0.29	0.14	0.18	0.46	0.92	-0.41	0.08	0.52	0.41	0.5	0.42	0.87	0.08	0.72	0.14	0.21		0.43	0.85	0.88	0.42	0.46	0.7	0.25	-0.43
Total Current Assets	1.0	-0.09	0.85	0.86	1.0	0.45	-0.99	0.91	0.23	0.99	0.89	0.99	0.6	0.65	0.61	0.27	0.88	0.43		0.61	0.53	0.99	0.35	0.57	0.97	0.21
Common Stock	0.63	-0.21	0.41	0.46	0.64	0.93	-0.6	0.22	0.64	0.59	0.73	0.6	0.99	0.41	0.53	0.15	0.48	0.85	0.61		0.85	0.57	0.24	0.53	0.41	-0.12
Property Plant Equipment	0.54	-0.24	0.24	0.26	0.56	0.87	-0.5	0.21	0.24	0.49	0.58	0.51	0.86	0.26	0.69	0.26	0.29	0.88	0.53	0.85		0.52	0.38	0.67	0.36	-0.36
Net Tangible Assets	0.99	-0.14	0.85	0.86	0.99	0.42	-0.99	0.92	0.18	0.99	0.88	0.99	0.57	0.65	0.61	0.25	0.88	0.42	0.99	0.57	0.52		0.33	0.58	0.98	0.2
Other Stockholder Equity	0.33	0.07	-0.09	-0.08	0.35	0.35	-0.28	0.3	0.15	0.28	0.08	0.3	0.23	-0.33	0.78	0.45	-0.04	0.46	0.35	0.24	0.38	0.33		0.68	0.34	-0.57
Other Liab	0.55	-0.54	0.18	0.2	0.57	0.52	-0.55	0.41	0.2	0.53	0.37	0.55	0.55	0.02	0.95	0.13	0.24	0.7	0.57	0.53	0.67	0.58	0.68		0.51	-0.6
Retained Earnings Total Equity	0.96	-0.08	0.85	0.85	0.96	0.25	-0.96	0.98	0.08	0.96	0.8	0.96	0.4	0.62	0.55	0.28	0.87	0.25	0.97	0.41	0.36	0.98	0.34	0.51		0.26
Non Currrent Assets Other	0.24	0.44	0.65	0.63	0.21	-0.27	-0.27	0.34	-0.13	0.3	0.41	0.26	-0.15	0.68	-0.54	-0.3	0.6	-0.43	0.21	-0.12	-0.36	0.2	-0.57	-0.6	0.26

Click cells to compare fundamentals

XBiotech Account Relationship Matchups

XBiotech fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	816.9M	353.7M	275.2M	246.1M	226.6M	209.4M
Other Current Liab	53.5M	1.4M	1.4M	1.6M	3.5M	6.5M
Total Current Liabilities	60.2M	4.0M	3.5M	4.1M	6.1M	9.4M
Total Stockholder Equity	755.6M	348.6M	269.4M	240.4M	218.8M	199.2M
Property Plant And Equipment Net	25.2M	27.3M	28.3M	26.3M	24.9M	22.6M
Net Debt	(714.6M)	(237.4M)	(237.0M)	(157.3M)	(200.0M)	(210.0M)
Retained Earnings	430.9M	97.6M	5.2M	(27.7M)	(52.3M)	(54.9M)
Accounts Payable	2.1M	2.5M	2.1M	2.4M	2.5M	2.5M
Cash	714.6M	237.4M	237.0M	157.3M	200.0M	163.9M
Non Current Assets Total	100.6M	27.9M	28.3M	26.3M	24.9M	29.6M
Cash And Short Term Investments	714.6M	237.4M	237.0M	217.5M	200.0M	169.4M
Common Stock Total Equity	324.8M	249.8M	262.3M	267.3M	307.4M	244.1M
Common Stock Shares Outstanding	46.3M	30.8M	30.0M	30.4M	30.4M	36.4M
Liabilities And Stockholders Equity	816.9M	353.7M	275.2M	246.1M	226.6M	209.4M
Non Current Liabilities Total	1.1M	1.1M	2.3M	1.6M	1.7M	870.2K
Other Current Assets	1.7M	84.4M	934K	601K	760K	722K
Total Liab	61.2M	5.1M	5.8M	5.7M	7.8M	10.2M
Property Plant And Equipment Gross	25.2M	27.3M	44.0M	26.3M	43.1M	25.8M
Total Current Assets	716.3M	325.9M	246.9M	219.8M	201.7M	179.8M
Accumulated Other Comprehensive Income	(255K)	(106K)	1.3M	2.0M	826K	0.0
Common Stock	324.8M	249.8M	262.3M	267.3M	271.2M	248.6M
Property Plant Equipment	25.2M	27.3M	28.3M	26.3M	30.2M	20.6M
Net Tangible Assets	755.6M	348.6M	269.4M	240.4M	276.5M	236.7M
Other Stockholder Equity	(255K)	(106K)	1.3M	2.0M	826K	0.0
Other Liab	1.1M	1.1M	2.3M	1.6M	1.9M	2.0M
Retained Earnings Total Equity	430.9M	97.6M	5.2M	(27.7M)	(31.9M)	(33.5M)
Non Currrent Assets Other	27.3M	75M	(1.1M)	(1.7M)	(1.5M)	(1.4M)
Net Invested Capital	755.6M	348.6M	269.4M	240.4M	218.8M	304.0M
Net Working Capital	656.1M	321.9M	243.4M	215.8M	195.6M	263.6M
Capital Stock	324.8M	249.8M	262.3M	267.3M	271.2M	220.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for XBiotech Stock Analysis

When running XBiotech's price analysis, check to measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC